Head-to-head · Cost-Efficiency Index
LVNG RX vs TRT Nation
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
LVNG RX
Cost-first shoppers who want price-sensitive shoppers who are comfortable verifying the real charge at checkout given the markdown-style pricing display.
Visit LVNG RXTRT Nation
Cost-first shoppers who want men wanting flat-rate compounded tirzepatide alongside a TRT-focused platform.
Visit TRT NationThe verdict
LVNG RX and TRT Nation tie on the Cost-Efficiency Index at 51/100, so neither wins outright on the numbers. For most shoppers we'd start with LVNG RX (ranked #400, a hair above #403) — Cost-first shoppers who want price-sensitive shoppers who are comfortable verifying the real charge at checkout given the markdown-style pricing display. But TRT Nation is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs LVNG RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | LVNG RX | TRT Nation |
|---|---|---|
| Cost-Efficiency Index | 51/100 | 51/100 |
| Semaglutide / mo | $149/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide / mo | $249/mo (starting dose, compounded) | $219/mo |
| Semaglutide / yr (modeled) | $1,788 | — |
| Tirzepatide / yr (modeled) | $2,988 | $2,628 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #400 | #403 |
LVNG RX
51/100Where the value is
- '$0 if not approved' removes financial risk from a declined consult
- Clear headline pricing for both semaglutide and tirzepatide
- Explicit disclaimer that independent licensed practitioners make all prescribing decisions
The tradeoffs
- Uses strikethrough 'was/now' pricing display that anchors against a higher reference price of unclear provenance
- An unreconciled second price ($99/mo) appears alongside the primary $149/mo headline for semaglutide
TRT Nation
51/100Where the value is
- Flat $219/mo tirzepatide regardless of dose escalation
- Tirzepatide compounded with B12 to reduce nausea
- Flat plan includes unlimited virtual provider visits
The tradeoffs
- Weight loss is secondary to core TRT business
- Specific pharmacy partner and 503A status not disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.